Skip to content
★ Sign in to follow
JL

Jacopo Leonardi

CEO
Baxalta Inc
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 07 Jun 2016 for Baxalta Inc.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Jacopo Leonardi: trading record in brief

This profile gathers the share dealings of Jacopo Leonardi in Baxalta Inc. In total, 16 filings cover trades dated from 1 July 2015 to 3 June 2016.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 7 June 2016 came the latest disclosure, a transaction in Baxalta Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jacopo Leonardi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    1,033 shares0Common Stock, par value $0.01 per shareSEC:0000899243-16-021972:0
  • ●
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    56,364 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-021972:1
  • ●
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    1,095 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-021972:2
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    3,457 USD23SEC
    87 shares@ US$39.748.9% of flowCommon Stock, par value $0.01 per shareSEC:0000899243-16-015531:0
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    27,976 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-015431:0
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    22,951 USD28SEC
    584 shares@ US$39.3059.6% of flowCommon Stock, par value $0.01 per shareSEC:0000899243-16-015431:1
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    4,302 USD23SEC
    109 shares@ US$39.4711.1% of flowCommon Stock, par value $0.01 per shareSEC:0000899243-16-015431:2
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    178 shares0Common Stock, par value $0.01 per shareSEC:0000899243-16-013636:0
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    182 shares0Common Stock, par value $0.01 per shareSEC:0000899243-16-013636:2
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    8,112 USD24SEC
    208 shares@ US$39.0020.4% of flowCommon Stock, par value $0.01 per shareSEC:0000899243-16-013636:1
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    29,208 USD0SEC
    835 shares@ US$34.98Common Stock, par value $0.01 per shareSEC:0000899243-15-009344:0
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    44 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-003075:0
  • ◆
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    56 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-003075:1
  • ●
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    3,570 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-000641:0
  • ●
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    24,211 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-000641:1
  • ●
    EVP and President, ImmunologyExecutivesBaxalta Inc
    0SEC
    1,108 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-000641:2

16 of 16 declarations